跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,645 条关于
“J. Wood Capital Advisors LLC”
全部
13,645
临床试验
6,400
药物
637
机构
1,948
资讯
4,660
去年
Sarepta Therapeutics Refinances $700M Convertible Notes to Strengthen Financial Position
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
去年
Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues
2个月前
Spero Therapeutics Secures $105 Million Non-Dilutive Royalty Financing to Advance Anti-CD40L Antibody SP001
去年
Danforth Advisors Acquires PharmaDirections to Create Comprehensive Drug Development Platform
上个月
Trinity Biotech Secures $7.0 Million Investment from Perceptive Advisors and Regains Nasdaq Compliance
去年
BBOT Completes $382 Million SPAC Merger to Advance Next-Generation RAS-Targeted Cancer Therapeutics
去年
Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6 Billion, Bolstering Neuroscience Portfolio
去年
J&J Discontinues Depression Trials for Aticaprant After Insufficient Efficacy Results
去年
J&J Discontinues Seltorexant Trial in Alzheimer's, Citing Portfolio Prioritization
第 1 页，共 466 页
上一页
下一页
